Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracameral marcaine vs lidocaine for postoperative pain after cataract surgery with IV sedation
IRCT20210902052364N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine and lidocaine in cataract (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Sep 2021; status: completed.
02
Drugs
bupivacainelidocaine
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20210902052364N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210902052364N1.